|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/00 | |
| C07K 14/745 | |||
| C12N 9/64 |
| (11) | Patento numeris | 1745141 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05766825.3 |
| Europos patento paraiškos padavimo data | 2005-05-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-01-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-01-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/052024 |
| Data | 2005-05-03 |
| (87) | Numeris | WO 2005/111225 |
| Data | 2005-11-24 |
| (30) | Numeris | Data | Šalis |
| 200400712 | 2004-05-04 | DK | |
| 200400882 | 2004-06-04 | DK |
| (72) |
KLAUSEN, Niels Kristian, DK
RASMUSSEN, Daniel, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | O-LINKED GLYCOFORMS OF FAKTOR VII AND METHOD TO MANUFACTURE THEM |
| O-LINKED GLYCOFORMS OF FAKTOR VII AND METHOD TO MANUFACTURE THEM |